PATENT CLAIM ANALYSIS

Application Number: 16162335
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "422000"]

Abstract:
Disclosed herein are methods and pharmaceutical compositions for sustained release of anticancer agents. Such pharmaceutical compositions may provide a burst-free, sustained release of one or more anticancer agents and may include a plurality of poly(lactic-co-glycolic) acid (PLGA) microparticles encapsulating the one or more anticancer agents.

Claim (Index 51):
The pharmaceutical composition of  claim 49 , wherein the ratio of poly-lactide to poly-glycolide in the PLGA polymer units is 50:50 by weight.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.55882
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12664792', '11607382', '13422994', '14461884', '15349985']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533902523898304
- 35 USC 102 Novelty (BERT): 0.5159853611860353
- Combined Prediction Score: 0.7296497632694509
- Mean Citation Score: 239.511742
- Max Citation Score: 251.67445
- Similarity Product: 142.19945386832055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test